| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |